Skip to Content

Vadova FDA Approval Status

FDA Approved: No
Brand name: Vadova
Generic name: carbidopa and levodopa
Dosage form: Extended Release Tablets
Company: IMPAX Laboratories, Inc.
Treatment for: Parkinson's Disease

Vadova is an extended release formulation of carbidopa and levodopa under review for the treatment of Parkinson's disease. The FDA issued a non-approvable letter for Vadova in January 2008.

Development Timeline for Vadova

Jan 30, 2008IMPAX Receives FDA Non-Approvable Letter for Vadova; CompanyConsidering Options
Jan 18, 2007IMPAX Files Amendment to Vadova NDA

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.